Innovations in consumer genetic health are rapidly advancing-and pharma commercial thinking needs to catch up.
Craig Wylie
Advertisement
Articles by Craig Wylie
Advertisement
Latest Updated Articles
The Personalized Genetic Profile: It’s Time to AlignPublished: March 1st 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
5
